Warby Parker (WRBY)

• Market cap: $2.23B
• 1 day: 1.15%
• 5 days: -8.53%
• 1 month: -23.71%
• 3 months: -27.26%
• 6 months: 18.36%
• Year to date: -27.26%
• 1 year: 31.71%
• 5 years: -66.16%
• 10 years: -66.16%
• Sector: Healthcare
• Industry: Ophthalmic Goods

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

146% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 24

48% more capital invested

Capital invested by funds: $1.61B [Q3] → $2.38B (+$776M) [Q4]

17% more funds holding

Funds holding: 197 [Q3] → 231 (+34) [Q4]

2% more call options, than puts

Call options by funds: $42.5M | Put options by funds: $41.5M

0% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]

0.92% less ownership

Funds ownership: 97.75% [Q3] → 96.83% (-0.92%) [Q4]

5% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 73

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $23 25% upside
• Avg. target: $26 39% upside
• High target: $32 74% upside

7 analyst ratings

• positive: 2 29%
• neutral: 4 57%
• negative: 1 14%

UBS Mark Carden 50% 1-year accuracy 5 / 10 met price target	25% upside $23	Neutral Maintained	28 Feb 2025
Baird Mark Altschwager 26% 1-year accuracy 8 / 31 met price target	74% upside $32	Outperform Maintained	28 Feb 2025
Telsey Advisory Group Dana Telsey 27% 1-year accuracy 50 / 183 met price target	63% upside $30	Outperform Maintained	28 Feb 2025
Roth MKM Matt Koranda 20% 1-year accuracy 5 / 25 met price target	41% upside $26	Neutral Initiated	25 Feb 2025
Citigroup Paul Lejuez 41% 1-year accuracy 15 / 37 met price target	25% upside $23	Sell Downgraded	5 Feb 2025